<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sarcoma histologies with associated chromosomal translocations</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sarcoma histologies with associated chromosomal translocations</h1>
<div class="graphic"><div class="figure"><div class="ttl">Sarcoma histologies with associated chromosomal translocations</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1">Translocation</td> <td class="subtitle1">Genes</td> <td class="subtitle1">Type of fusion gene</td> </tr> <tr class="divider_top"> <td colspan="3"><strong>Ewing sarcoma (OMIM#133450)</strong></td> </tr> <tr> <td class="indent1">t(11;22)(q24;q12)</td> <td><em>EWSR1-FLI1</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(21;22)(q22;q12)</td> <td><em>EWSR1-ERG</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(7;22)(p22;q12)</td> <td><em>EWSR1-ETV1</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(17;22)(q12;q12)</td> <td><em>EWSR1-ETV4</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(2;22)(q35;q12)</td> <td><em>EWSR1-FEV</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(2;16)(q35;p11)</td> <td><em>FUS-FEV</em></td> <td>Transcription factor</td> </tr> <tr class="divider_bottom"> <td class="indent1">t(16;21)(p11;q24)</td> <td><em>FUS-ERG</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Undifferentiated round cell sarcoma with <em>BCOR</em>- or <em>CIC</em>-rearrangements</strong><sup>[1]</sup> <strong>(OMIM#300485, #612082, #606009)</strong></td> </tr> <tr> <td class="indent1">t(X;X)(p11;p11)</td> <td><em>BCOR-CCNB3</em></td> <td>Cell cycle progression</td> </tr> <tr class="divider_bottom"> <td class="indent1">t(4;19)(q35;q13) or t(10;19)(q26;q13)<sup>[1]</sup></td> <td><em>CIC-DUX4</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Clear cell sarcoma (OMIM#123803)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(12;22)(q13;q12)</td> <td><em>EWSR1-ATF1</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Desmoplastic small round cell tumor of the abdomen (OMIM#133450)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(11;22)(p13;q12)</td> <td><em>EWSR1-WT1</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Extraskeletal myxoid chondrosarcoma (OMIM#600542)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(9;22)(q22-31;q11-12)</td> <td><em>EWSR1-NR4A3</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Myxoid liposarcoma (OMIM#126337, #137070)</strong></td> </tr> <tr> <td class="indent1">t(12;16)(q13;p11)</td> <td><em>FUS-DDIT3</em> (<em>FUS-CHOP</em>)</td> <td>Transcription factor</td> </tr> <tr class="divider_bottom"> <td class="indent1">t(12;22)(q13;q12)</td> <td><em>EWSR1-CHOP</em> (<em>EWSR1-DDIT3</em>)</td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Alveolar rhabdomyosarcoma (OMIM#268220)</strong></td> </tr> <tr> <td class="indent1">t(2;13)(q35;q14)</td> <td><em>PAX3-FOXO1A</em>*</td> <td>Transcription factor</td> </tr> <tr class="divider_bottom"> <td class="indent1">t(1;13)(p36;q14)</td> <td><em>PAX7-FOXO1A</em>*</td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Congenital infantile spindle cell rhabdomyosarcoma</strong></td> </tr> <tr> <td class="indent1">t(6;6)(q24.1;q22.1)</td> <td><em>VGLL2-CITED2</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(6;8)(q22.1;q13.3)</td> <td><em>VGLL2-NCOA2</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(11;8)(p15.3;q13.3)</td> <td><em>TEAD1-NCOA2</em></td> <td>Transcription factor</td> </tr> <tr> <td class="indent1">t(2;8)(q36;q13.3)</td> <td><em>PAX3-NCOA2</em></td> <td>Transcription factor</td> </tr> <tr class="divider_bottom"> <td class="indent1">t(6;8)(p21.1;q13.3)</td> <td><em>SRF-NCOA2</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Synovial sarcoma (OMIM#312820)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(X;18)(p11;q11)</td> <td><em>SS18-SSX1</em>, <em>SSX2</em>, or <em>SSX4</em></td> <td>Remodels chromatin to alter transcription</td> </tr> <tr> <td colspan="3"><strong>Dermatofibrosarcoma protuberans (OMIM#607907)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(17;22)(q22;q13)</td> <td><em>COL1A1-PDGFB</em></td> <td>Growth factor</td> </tr> <tr> <td colspan="3"><strong>Congenital fibrosarcoma (OMIM#191316)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(12;15)(p13;q25)</td> <td><em>ETV6-NTRK3</em></td> <td>Transcription factor receptor</td> </tr> <tr> <td colspan="3"><strong>Inflammatory myofibroblastic tumor</strong></td> </tr> <tr> <td class="indent1 divider_bottom" rowspan="2">2p23 rearrangements</td> <td><em>TMP3-ALK</em></td> <td>Growth factor receptor</td> </tr> <tr class="divider_bottom"> <td><em>TMP4-ALK</em></td> <td>Growth factor receptor</td> </tr> <tr> <td colspan="3"><strong>Alveolar soft part sarcoma (OMIM#606243)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">t(X;17)(p11.2;q25)</td> <td><em>ASPL-TFE3</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Solitary fibrous tumor (OMIM#602381)</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">Inversion 12q13</td> <td><em>NAB2-STAT6</em></td> <td>Transcription factor</td> </tr> <tr> <td colspan="3"><strong>Epithelioid hemangioendothelioma</strong></td> </tr> <tr> <td class="indent1">t(1;3)(p36;q25)</td> <td><em>WWTR1-CAMTA1</em></td> <td>Transcription factor</td> </tr> </tbody></table></div><div class="graphic_lgnd">Note that for some tumors, notably Ewing sarcoma, multiple variant translocations have been observed involving related genes.</div><div class="graphic_footnotes">OMIM: Online Mendelian Inheritance in Man, available at http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim.<br/>* <em>FOXO1A</em> gene, also known as the <em>FKHR</em> gene.</div><div class="graphic_reference">Reference:

<ol>
<li>Pappo AS, Dirksen U. Rhabdomyosarcoma, Ewing sarcoma, and other round cell sarcomas. J Clin Oncol 2018; 36:168.</li>
</ol>

Adapted with permission from: Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nature Reviews: Cancer 2003; 3:685. Copyright Â© 2003 MacMillan Magazines Ltd.</div><div id="graphicVersion">Graphic 64666 Version 9.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
